Technology News and Research

RSS

Yale researchers use AB SCIEX's QTRAP technology to synthesize phosphoproteins

AB SCIEX, a global leader in life science analytical technologies, today announced that Yale University researchers used QTRAP technology to prove the validity of a new approach to synthesize phosphoproteins.

28 Sep 2011

University of Utah organic chemist wins National Medal of Science

University of Utah organic chemist Peter J. Stang has won a National Medal of Science - the highest U.S. honor for a scientist or engineer - and is tentatively scheduled to be honored by President Barack Obama at the White House later this year.

28 Sep 2011

Some stroke patients may benefit from treatment outside the typical 3 hour window

Stroke victims may have a longer window of opportunity to receive treatment to save their brain cells, demonstrates a literature review published by University of Alberta medical researchers in Lancet Neurology.

28 Sep 2011

Dialog Devices receives CE mark and ISO certification for Padd

A ground-breaking device which "sees" beneath the skin to spot circulation problems has passed an important milestone on its journey to commercialisation.

28 Sep 2011

UCSF neuroscientist wins PECASE award for research into addiction

Linda Wilbrecht, PhD, a neuroscientist at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco (UCSF), is one of 94 researchers named today by President Obama as a recipient of the Presidential Early Career Awards for Scientists and Engineers (PECASE).

28 Sep 2011

Engager Transcatheter Aortic Valve Implantation System pivotal trial to be conducted at 11 European centers

Medtronic, Inc. today announced the start of the Engager European Pivotal Trial to pursue CE Mark for the Engager Transcatheter Aortic Valve Implantation System in patients suffering from severe aortic stenosis.

From Medtronic 28 Sep 2011

UCI professor wins Presidential Early Career Award for Scientists & Engineers

Rommie Amaro, UC Irvine assistant professor of pharmaceutical sciences and computer science, has been selected by President Obama for the Presidential Early Career Award for Scientists & Engineers.

28 Sep 2011

USPTO issues patent to Precision BioSciences' engineered meganucleases

Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued U.S. Pat. No. 8,021,867. The '867 patent is owned by Duke University and exclusively licensed to Precision BioSciences.

27 Sep 2011

Men with localized prostate cancer benefit from intensity modulated radiation therapy

Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

27 Sep 2011

Close link between SF3B1 mutation and specific feature of myelodysplastic syndromes

Geneticists have discovered that a gene involved in the modification of ribonucleic acid (RNA) is mutated in a significant proportion of people with a collection of blood cancers called myelodysplastic syndromes.

27 Sep 2011

UCLA researchers sequence complete genomes of 17 strains of mice

For decades, laboratory mice have been widely used in research aimed at understanding which genes are involved in various illnesses. But actual variations in past gene sequences of mice were unknown. While researchers were able to determine that a variant affecting disease was in a certain region, they couldn't pinpoint the exact set of variants in that region.

27 Sep 2011

UCSF, QuantiaMD develop new DiabetesIQ mobile phone app

A new interactive mobile phone app called DiabetesIQ, released this week, challenges people to test their knowledge of diabetes and to compete with one another as they learn about the complexities of the disease, which affects more than 25 million Americans, including 4 million Californians.

27 Sep 2011

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.

27 Sep 2011

Collegium completes Type A meeting with FDA for COL-003 Phase III chronic low back pain study

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has successfully completed a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the proposed Phase III clinical study for COL-003, the Company's tamper-resistant, extended release oxycodone product utilizing its proprietary DETERx technology.

27 Sep 2011

Aesculap acquires assets of Aragon Surgical

Aesculap announced today that it has acquired the assets of Aragon Surgical, Inc. Aragon Surgical specializes in advanced radio frequency (RF) electrosurgical instruments for tissue fusion and cutting.

27 Sep 2011

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Pacira Pharmaceuticals, Inc. today announced that the company's lead investigational product for postsurgical pain management, EXPAREL, was highlighted in the "Hot Topics in Plastic Surgery" panel at the annual scientific assembly of the American Society of Plastic Surgeons (ASPS) in Denver, Colo.

26 Sep 2011

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

IsoRay, a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that doctors at New York Presbyterian Hospital/ Weill Cornell Medical Center have performed the world's first treatment of metastasized brain cancer using IsoRay's Cesium-131 brachytherapy seeds.

26 Sep 2011

Gold nanowires in engineered cardiac patches could help heart attack patients

A team of physicians, engineers and materials scientists at Children's Hospital Boston and the Massachusetts Institute of Technology have used nanotechnology and tiny gold wires to engineer cardiac patches, with cells all beating in time, that could someday help heart attack patients.

26 Sep 2011

Percutaneous hepatic perfusion extends survival time for melanoma patients

Melanoma of the eye frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.

26 Sep 2011

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.

26 Sep 2011

Technology News and Research

Yale researchers use AB SCIEX's QTRAP technology to synthesize phosphoproteins

University of Utah organic chemist wins National Medal of Science

Some stroke patients may benefit from treatment outside the typical 3 hour window

Dialog Devices receives CE mark and ISO certification for Padd

UCSF neuroscientist wins PECASE award for research into addiction

Engager Transcatheter Aortic Valve Implantation System pivotal trial to be conducted at 11 European centers

UCI professor wins Presidential Early Career Award for Scientists & Engineers

USPTO issues patent to Precision BioSciences' engineered meganucleases

Men with localized prostate cancer benefit from intensity modulated radiation therapy

Close link between SF3B1 mutation and specific feature of myelodysplastic syndromes

UCLA researchers sequence complete genomes of 17 strains of mice

UCSF, QuantiaMD develop new DiabetesIQ mobile phone app

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Collegium completes Type A meeting with FDA for COL-003 Phase III chronic low back pain study

Aesculap acquires assets of Aragon Surgical

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

Gold nanowires in engineered cardiac patches could help heart attack patients

Percutaneous hepatic perfusion extends survival time for melanoma patients

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News